Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$209.01 - $232.56 $2,717 - $3,023
-13 Reduced 0.13%
9,945 $2.17 Million
Q4 2023

Jan 10, 2024

SELL
$197.69 - $227.29 $144,511 - $166,148
-731 Reduced 6.84%
9,958 $2.26 Million
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $167,273 - $184,454
832 Added 8.44%
10,689 $2.15 Million
Q2 2023

Aug 15, 2023

BUY
$211.93 - $241.33 $110,839 - $126,215
523 Added 5.6%
9,857 $2.38 Million
Q1 2023

May 03, 2023

BUY
$213.32 - $257.83 $29,651 - $35,838
139 Added 1.51%
9,334 $2.14 Million
Q4 2022

Feb 02, 2023

BUY
$203.72 - $248.97 $85,154 - $104,069
418 Added 4.76%
9,195 $2.17 Million
Q3 2022

Oct 31, 2022

BUY
$204.81 - $262.19 $227,339 - $291,030
1,110 Added 14.48%
8,777 $1.8 Million
Q2 2022

Jul 14, 2022

BUY
$213.86 - $277.87 $29,298 - $38,068
137 Added 1.82%
7,667 $1.8 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $422,986 - $485,437
1,628 Added 27.58%
7,530 $1.99 Million
Q4 2021

Jan 31, 2022

BUY
$271.6 - $314.21 $1.16 Million - $1.34 Million
4,260 Added 259.44%
5,902 $1.85 Million
Q3 2021

Oct 18, 2021

BUY
$274.82 - $308.34 $21,985 - $24,667
80 Added 5.12%
1,642 $462,000
Q2 2021

Jul 20, 2021

BUY
$251.87 - $278.14 $2,014 - $2,225
8 Added 0.51%
1,562 $431,000
Q1 2021

May 03, 2021

BUY
$204.88 - $255.03 $1,843 - $2,295
9 Added 0.58%
1,554 $397,000
Q4 2020

Jan 13, 2021

SELL
$186.91 - $214.42 $17,195 - $19,726
-92 Reduced 5.62%
1,545 $315,000
Q3 2020

Oct 14, 2020

SELL
$167.03 - $201.3 $25,388 - $30,597
-152 Reduced 8.5%
1,637 $308,000
Q2 2020

Jul 16, 2020

SELL
$113.31 - $182.44 $906 - $1,459
-8 Reduced 0.45%
1,789 $298,000
Q1 2020

Apr 17, 2020

SELL
$104.32 - $195.28 $5,320 - $9,959
-51 Reduced 2.76%
1,797 $228,000
Q4 2019

Jan 14, 2020

SELL
$163.48 - $173.61 $8,500 - $9,027
-52 Reduced 2.74%
1,848 $312,000
Q3 2019

Oct 24, 2019

BUY
$159.77 - $178.1 $76,210 - $84,953
477 Added 33.52%
1,900 $320,000
Q2 2019

Jul 15, 2019

SELL
$144.16 - $172.9 $53,627 - $64,318
-372 Reduced 20.72%
1,423 $246,000
Q1 2019

Apr 15, 2019

SELL
$123.7 - $156.3 $149,924 - $189,435
-1,212 Reduced 40.31%
1,795 $275,000
Q4 2018

Jan 29, 2019

SELL
$120.82 - $174.09 $167,094 - $240,766
-1,383 Reduced 31.5%
3,007 $380,000
Q3 2018

Oct 16, 2018

SELL
$167.67 - $188.27 $4,527 - $5,083
-27 Reduced 0.61%
4,390 $762,000
Q2 2018

Jul 11, 2018

BUY
$160.33 - $189.41 $71,507 - $84,476
446 Added 11.23%
4,417 $793,000
Q1 2018

Apr 05, 2018

BUY
$161.53 - $178.11 $33,113 - $36,512
205 Added 5.44%
3,971 $643,000
Q4 2017

Feb 02, 2018

BUY
$147.99 - $163.95 $50,908 - $56,398
344 Added 10.05%
3,766 $601,000
Q3 2017

Oct 24, 2017

BUY
$149.47 - $160.56 $22,569 - $24,244
151 Added 4.62%
3,422 $516,000
Q2 2017

Aug 10, 2017

BUY
N/A
3,271
3,271 $504,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.